Care needed with i.v. acetaminophen

Palmer, Katherine A.; Shane, Rita
October 2011
American Journal of Health-System Pharmacy;10/1/2011, Vol. 68 Issue 19, p1775
Academic Journal
The article discusses the safety and logistic challenges associated with administration of the FDA approved intravenous (i.v.) acetaminophen formulation. It explores several dosing situations for i.v. acetaminophen administration and highlights the risk of acetaminophen toxicity, and acute liver failure (ALF) as reported by a population-based surveillance study.


Related Articles

  • ISMP Medication Error Report Analysis - FDA Advise-ERR: FDA Approves Hydromorphone Labeling Revisions to Reduce Medication Errors; Differentiating Penicillin from Penicillamine; Infusion Reconnected to the Wrong Patient; Spell Out Acetaminophen on Prescription Labels Cohen, Michael R.; Smetzer, Judy L. // Hospital Pharmacy;Jan2012, Vol. 47 Issue 1, p10 

    The article discusses the analysis of Institute for Safe Medication Practices (ISMP) on the medication error reports. It mentions the use of hydromorphone labeling, which has been approved by the U.S. Food and Drug Administration (FDA) in reducing the occurrence of medication errors. It...

  • FDA approves pertuzumab for breast cancer. Traynor, Kate // American Journal of Health-System Pharmacy;7/15/2012, Vol. 69 Issue 14, p1178 

    The article reports that the FDA and Genentech on June 8, 2012 announced the approval of pertuzumab injection as part of a first-line treatment regimen for patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer. The drug will be sold as Perjeta and must...

  • FDA limits paracetamol strength to reduce overdose potential.  // Reactions Weekly;1/22/2011, Issue 1335, p1 

    The article reports that the U.S. Food and Drug Administration (FDA) is asking prescription drug manufacturers to limit the amount of paracetamol in their products to 325 milligrams in order to prevent accidental overdose.

  • Ado-trastuzumab emtansine: name confusion.  // WHO Drug Information;2013, Vol. 27 Issue 3, p220 

    The article reports on a 2013 drug safety communication which the U.S. Food and Drug Administration issued in 2013 to inform medical professionals about the potential for medical mistakes linked to the incorrect name of the breast cancer drug trastuzumab emtansine, which could be mistaken for...

  • US FDA votes for ban or boxed warning on paracetamol combos.  // Reactions Weekly;7/11/2009, Issue 1260, p2 

    The article reports on actions taken by the U.S. Food and Drug Administration (FDA) to help reduce the risk of overdose in patients receiving dextropropoxyphene-containing medications like Darvocet and Darvon in response to data linking the drug with fatal overdoses. The steps taken by the...

  • FDA actions. Elliott, William T. // Primary Care Reports;Jun2012 Pharmacology Watch, p2 

    The article reports that the FDA has approved Avanafil, a PDE5 inhibitor for the treatment of erectile dysfunction (ED), and requires a labeling change on finasteride which is a Merck's testosterone blocker.

  • Approvals, Submission, and Important Labeling Changes for US Marketed Pharmaceuticals. Baker, Danial E. // Hospital Pharmacy;Jun2012, Vol. 47 Issue 6, p471 

    Several tables are presented which provide data related to drug approvals, subsmission, and labeling which include the new drugs being approved by the U.S. Food and Drug Administration (FDA) from March 17 to April 13, 2012, newly FDA-approved dosage forms and indications from March 17 to April...

  • Pharmacists have role to play in preventing acetaminophen overdoses. Blank, Christine // Drug Topics;Jan2015, Vol. 159 Issue 1, p12 

    The article discusses what healthcare professionals and pharmacists can do to educate consumers and patients about acetaminophen overdosing. It presents views of Leiana Oswald of Roseman University of Health Sciences in Henderson, Nevada, on the issue, mentions the U.S. Food & Drug...

  • Intravenous Acetaminophen. H. T. // School Health Alert;May2012, Vol. 27 Issue 9, p5 

    The article reports that the U.S. Food and Drug Administration has permitted the introduction of a new formulation of acetaminophen in the U.S.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics